Interleucina 2 Humana (IL-2) Promoção da Regulação Imunológica e Clínica Resultados/Human Interleukin 2 (IL-2) Promotion of Immune Regulation and Clinical Outcomes: A Review

Capobianco, Marcela Petrolini; Cassiano, Gustavo Capatti; Furini, Adriana Antônia da Cruz; Melo, Luciane Moreno Storti de; Domingos, Cláudia Regina Bonini; Machado, Ricardo Luiz Dantas.
J Cytokine Biol ; 1(2): 1-4, 2016.
Artigo em Inglês | Instituto Evandro Chagas (SOPHIA) | ID: iec-15789

Documentos relacionados

  1. Short-term temperature fluctuations increase disease in a Daphnia-parasite infectious disease system.
  2. How does academia respond to the burden of infectious and parasitic disease?
  3. MicroRNAs in infectious diseases: potential diagnostic biomarkers and therapeutic targets.
  4. Hospital admissions due to infectious and parasitic diseases in England and Wales between 1999 and 2019: an ecological study.
  5. [Research Development on the Protective Effect of Parasitic Infection against Rheumatoid Arthritis].
  6. The IL-33/ST2 Axis in Immune Responses Against Parasitic Disease: Potential Therapeutic Applications.
  7. A Candide response to Panglossian accusations by Randolph and Dobson: biodiversity buffers disease.
  8. Environmental Persistence of the World's Most Burdensome Infectious and Parasitic Diseases.
  9. Commentary on 'A Candide response to Panglossian accusations by Randolph and Dobson: biodiversity buffers disease' by Dr R. Ostfeld (Parasitology 2013, in press).
  10. After malaria: which parasitic disease will China eliminate next?